Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy.

Category Primary study
JournalGut
Year 2022
This article has no abstract
Epistemonikos ID: 3cddbff7906bc4bf0af9f86af7c2c1514da15eed
First added on: Nov 25, 2021